New Biomarkers of Bone and Mineral Metabolism as Risk Factors for Morbidity/Mortality in Chronic Kidney Disease Patients Not Requiring Dialysis
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Biological, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To evaluate the relationships between bone mineral metabolism markers (osteoprotegerin, fibroblast growth factor 23) at inclusion and the occurence of cardiovascular events during a 7 year follow-up.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 95
Healthy Volunteers: f
View:
• Patient who has signed the written consent form
• Patient with chronic renal failure defined by glomerular filtration rate (GFR) but without dialysis therapy
Locations
Other Locations
France
AIDER
RECRUITING
Montpellier
CHU Montpellier, Cardiology department
ACTIVE_NOT_RECRUITING
Montpellier
CHU Montpellier, Endocrinology department
RECRUITING
Montpellier
CHU Montpellier, Intensive care unit
ACTIVE_NOT_RECRUITING
Montpellier
CHU Montpellier, Internal medicine department
ACTIVE_NOT_RECRUITING
Montpellier
CHU Montpellier, Nephrology department
RECRUITING
Montpellier
AIDER
NOT_YET_RECRUITING
Saint-jean-de-védas
Contact Information
Primary
Jean-Paul CRISTOL, Prof
jp-cristol@chu-montpellier.fr
+33(0)4 67 33 83 15
Backup
Marion Morena, PhD
m-morenacarrere@chu-montpellier.fr
+33(0)4 11 75 98 93
Time Frame
Start Date: 2013-03-12
Estimated Completion Date: 2031-06
Participants
Target number of participants: 250
Treatments
Experimental: Cardiovascular risk evaluation
Measurement at inclusion of plasma osteoprotegerin level, plasma fibroblast growth factor 23 level, vascular calcification score and record of cardiovascular events during the 3 year follow-up
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier